loadpatents
Patent applications and USPTO patent grants for AMMENDOLA; Virginia.The latest application filed is for "adenovirus polynucleotides and polypeptides".
Patent | Date |
---|---|
Adenovirus Polynucleotides And Polypeptides App 20220275397 - AMMENDOLA; Virginia ;   et al. | 2022-09-01 |
Adenovirus polynucleotides and polypeptides Grant 11,414,679 - Ammendola , et al. August 16, 2 | 2022-08-16 |
Adenovirus Polynucleotides And Polypeptides App 20220220157 - AMMENDOLA; Virginia ;   et al. | 2022-07-14 |
Adenovirus Polynucleotides And Polypeptides App 20220204566 - COLLOCA; Stefano ;   et al. | 2022-06-30 |
Chimpanzee Adenovirus Constructs With Lyssavirus Antigens App 20220112245 - AMMENDOLA; Virginia ;   et al. | 2022-04-14 |
Replication competent adenoviral vectors Grant 11,268,108 - Ammendola , et al. March 8, 2 | 2022-03-08 |
Chimpanzee Adenoviral Vector-based Filovirus Vaccines App 20220064669 - Sullivan; Nancy J. ;   et al. | 2022-03-03 |
Adenovirus polynucleotides and polypeptides Grant 11,254,710 - Colloca , et al. February 22, 2 | 2022-02-22 |
Adenovirus polynucleotides and polypeptides Grant 11,254,711 - Ammendola , et al. February 22, 2 | 2022-02-22 |
Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof Grant 11,214,599 - Colloca , et al. January 4, 2 | 2022-01-04 |
Chimpanzee Adenovirus Constructs With Lyssavirus Antigens App 20210269486 - AMMENDOLA; Virginia ;   et al. | 2021-09-02 |
Adenovirus Polynucleotides And Polypeptides App 20210246468 - AMMENDOLA; Virginia ;   et al. | 2021-08-12 |
Replication Competent Adenoviral Vectors App 20210189421 - AMMENDOLA; Virginia ;   et al. | 2021-06-24 |
Hepatitis B Immunisation Regimen And Compositions App 20210154290 - AMMENDOLA; Virginia ;   et al. | 2021-05-27 |
Hepatitis B Immunisation Regimen And Compositions App 20210069322 - AMMENDOLA; Virginia ;   et al. | 2021-03-11 |
Novel Adenovirus App 20210060150 - COLLOCA; Stefano ;   et al. | 2021-03-04 |
Chimpanzee Adenoviral Vector-based Filovirus Vaccines App 20200149069 - Sullivan; Nancy J. ;   et al. | 2020-05-14 |
Adenovirus Polynucleotides and Polypeptides App 20200140886 - AMMENDOLA; Virginia ;   et al. | 2020-05-07 |
Simian Adenovirus Nucleic Acid-and Amino Acid-sequences, Vectors Containing Same, And Uses Thereof App 20200102352 - Colloca; Stefano ;   et al. | 2020-04-02 |
Chimpanzee adenoviral vector-based filovirus vaccines Grant 10,584,355 - Sullivan , et al. | 2020-03-10 |
Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof Grant 10,544,192 - Colloca , et al. Ja | 2020-01-28 |
Adenovirus Polynucleotides And Polypeptides App 20190300905 - AMMENDOLA; Virginia ;   et al. | 2019-10-03 |
Novel Adenovirus App 20180216081 - COLLOCA; Stefano ;   et al. | 2018-08-02 |
Adenovirus Polynucleotides and Polypeptides App 20180170972 - COLLOCA; Stefano ;   et al. | 2018-06-21 |
Simian Adenovirus Nucleic Acid-and Amino Acid-sequences, Vectors Containing Same, And Uses Thereof App 20180057540 - Colloca; Stefano ;   et al. | 2018-03-01 |
Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof Grant 9,718,863 - Colloca , et al. August 1, 2 | 2017-08-01 |
Chimpanzee Adenoviral Vector-based Filovirus Vaccines App 20170044571 - Sullivan; Nancy J. ;   et al. | 2017-02-16 |
Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein Grant 9,526,777 - Sullivan , et al. December 27, 2 | 2016-12-27 |
Chimpanzee Adenoviral Vector-based Filovirus Vaccines App 20130101618 - Sullivan; Nancy J. ;   et al. | 2013-04-25 |
Simian Adenovirus Nucleic Acid- And Amino Acid-sequences, Vectors Containing Same, And Uses Thereof App 20120027788 - Colloca; Stefano ;   et al. | 2012-02-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.